This document analyzes MediHealth's potential acquisition of Athena, a skin care company. It considers whether to license or buy Athena, pricing and distribution strategies, and marketing approaches. It recommends buying Athena, using premium pricing in mass markets, and a 360 marketing strategy. Financial projections show the strategy would be profitable, with a net present value of $173 million and 21% internal rate of return. A sensitivity analysis also supports the recommendations.